Joost P. A. Kuijer

Joost P. A. Kuijer

Auto-generated profile, based on publicly available information

Joost P. A. Kuijer

Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, the Netherlands

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2006 in NeuroImage
Verified
Journal Article
Closed access
SGS.I. Gonçalves
S.I. Gonçalves
JMJ.C. de Munck
J.C. de Munck
PPP.J.W. Pouwels
P.J.W. Pouwels
RSR. Schoonhoven
R. Schoonhoven
JKJ.P.A. Kuijer
J.P.A. Kuijer
FSF.H. Lopes da Silva
F.H. Lopes da Silva

1 April 2018 in Radiology
Verified
Journal Article
Closed access
SHSven Haller
Sven Haller
MVMeike W. Vernooij
Meike W. Vernooij
JKJoost P. A. Kuijer
Joost P. A. Kuijer
ELElna-Marie Larsson
Elna-Marie Larsson
HJHans Rolf Jäger
Hans Rolf Jäger
FBFrederik Barkhof
Frederik Barkhof
Presence of multiple cerebral microbleeds might increase the risk of hemorrhage during anticoagulation or antiaggregation and thrombolysis, and large-scale studies and subsequent guidelines are in development. Cerebral microbleeds (CMBs), also referred to as microhemorrhages, appear on magnetic resonance (MR) images as hypointense foci notably at T2*-weighted or susceptibility-weighted (SW) imaging. CMBs are detected with increasing frequency because of the more widespread use of high magnetic field strength and of newer dedicated MR imaging techniques such as three-dimensional gradient-echo T2*-weighted and SW imaging. The imaging appearance of CMBs is mainly because of changes in local magnetic susceptibility and reflects the pathologic iron accumulation, most often in perivascular macrophages, because of vasculopathy. CMBs are depicted with a true-positive rate of 48%–89% at 1.5 T or 3.0 T and T2*-weighted or SW imaging across a wide range of diseases. False-positive “mimics” of CMBs occur at a rate of 11%–24% and include microdissections, microaneurysms, and microcalcifications; the latter can be differentiated by using phase images. Compared with postmortem histopathologic analysis, at least half of CMBs a...

1 April 2007 in NeuroImage
Verified
Journal Article
Closed access
JMJ.C. de Munck
J.C. de Munck
SGS.I. Gonçalves
S.I. Gonçalves
LHL. Huijboom
L. Huijboom
JKJ.P.A. Kuijer
J.P.A. Kuijer
PPP.J.W. Pouwels
P.J.W. Pouwels
FSF.H. Lopes da Silva
F.H. Lopes da Silva

8 March 2016 in Brain
Verified
Journal Article
Closed access
PDF file
IKIris D. Kilsdonk
Iris D. Kilsdonk
LJLaura E. Jonkman
Laura E. Jonkman
RKRoel Klaver
Roel Klaver
SVSusanne J. van Veluw
Susanne J. van Veluw
JZJaco J. M. Zwanenburg
Jaco J. M. Zwanenburg
JGJeroen J. G. Geurts
Jeroen J. G. Geurts
The relevance of cortical grey matter pathology in multiple sclerosis has become increasingly recognized over the past decade. Unfortunately, a large part of cortical lesions remain undetected on magnetic resonance imaging using standard field strength. In vivo studies have shown improved detection by using higher magnetic field strengths up to 7 T. So far, a systematic histopathological verification of ultra-high field magnetic resonance imaging pulse sequences has been lacking. The aim of this study was to determine the sensitivity of 7 T versus 3 T magnetic resonance imaging pulse sequences for the detection of cortical multiple sclerosis lesions by directly comparing them to histopathology. We obtained hemispheric coronally cut brain sections of 19 patients with multiple sclerosis and four control subjects after rapid autopsy and formalin fixation, and scanned them using 3 T and 7 T magnetic resonance imaging systems. Pulse sequences included T1-weighted, T2-weighted, fluid attenuated inversion recovery, double inversion recovery and T2*. Cortical lesions (type I–IV) were scored on all sequences by an experienced rater blinded to histopathology and clinical data. Staining was performed with antibodies against proteolipid protein and scored by a second reader blinded to magnetic resonance imaging and clinical data. Subsequently, magnetic resonance imaging images were matched to histopathology and sensitivity of pulse sequences was calculated. Additionally, a second unblinded (retrospective) scoring of magnetic resonance images was performed. Regardless of pulse sequence, 7 T magnetic resonance imaging detected more cortical lesions than 3 T. Fluid attenuated inversion recovery (7 T) detected 225% more cortical lesions than 3 T fluid attenuated inversion recovery (Z = 2.22, P < 0.05) and 7 T T2* detected 200% more cortical lesions than 3 T T2* (Z = 2.05, P < 0.05). Sensitivity of 7 T magnetic resonance imaging was influenced by cortical lesion type: 100% for type I (T2), 11% for type II (FLAIR/T2), 32% for type III (T2*), and 68% for type IV (T2). We conclude that ultra-high field 7 T magnetic resonance imaging more than doubles detection of cortical multiple sclerosis lesions, compared to 3 T magnetic resonance imaging. Unfortunately, (subpial) cortical pathology remains more extensive than 7 T magnetic resonance imaging can reveal.

1 February 2005 in NeuroImage
Verified
Journal Article
Closed access
ASAnda H. van Stegeren
Anda H. van Stegeren
RGRutger Goekoop
Rutger Goekoop
WEWalter Everaerd
Walter Everaerd
PSPhilip Scheltens
Philip Scheltens
FBFrederik Barkhof
Frederik Barkhof
SRSerge A.R.B. Rombouts
Serge A.R.B. Rombouts

1 March 2001 in JACC
Verified
Journal Article
Closed access
MGMarco J.W Götte
Marco J.W Götte
ARAlbert C van Rossum
Albert C van Rossum
JTJos W.R Twisk
Jos W.R Twisk
JKJoost P.A Kuijer
Joost P.A Kuijer
JMJ.Tim Marcus
J.Tim Marcus
CVCees A Visser
Cees A Visser